394 related articles for article (PubMed ID: 28755104)
1. The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.
van de Loo AJAE; Bervoets AC; Mooren L; Bouwmeester NH; Garssen J; Zuiker R; van Amerongen G; van Gerven J; Singh J; der Ark PV; Fedgchin M; Morrison R; Wajs E; Verster JC
Psychopharmacology (Berl); 2017 Nov; 234(21):3175-3183. PubMed ID: 28755104
[TBL] [Abstract][Full Text] [Related]
2. The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder.
Dijkstra FM; van de Loo AJ; Abdulahad S; Bosma ER; Hartog M; Huls H; Kuijper DC; de Vries E; Solanki B; Singh J; Aluisio L; Zannikos P; Stuurman FE; Jacobs GE; Verster JC
J Psychopharmacol; 2022 May; 36(5):614-625. PubMed ID: 35212235
[TBL] [Abstract][Full Text] [Related]
3. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
Ramaekers JG
J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
[TBL] [Abstract][Full Text] [Related]
4. Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.
Ramaekers JG; Conen S; de Kam PJ; Braat S; Peeters P; Theunissen EL; Ivgy-May N
Psychopharmacology (Berl); 2011 May; 215(2):321-32. PubMed ID: 21246188
[TBL] [Abstract][Full Text] [Related]
5. Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.
Wingen M; Bothmer J; Langer S; Ramaekers JG
J Clin Psychiatry; 2005 Apr; 66(4):436-43. PubMed ID: 15816785
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition.
Theunissen EL; Street D; Højer AM; Vermeeren A; van Oers A; Ramaekers JG
Clin Pharmacol Ther; 2013 Jun; 93(6):493-501. PubMed ID: 23588319
[TBL] [Abstract][Full Text] [Related]
7. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.
Vermeeren A; Sun H; Vuurman EF; Jongen S; Van Leeuwen CJ; Van Oers AC; Palcza J; Li X; Laethem T; Heirman I; Bautmans A; Troyer MD; Wrishko R; McCrea J
Sleep; 2015 Nov; 38(11):1803-13. PubMed ID: 26039969
[TBL] [Abstract][Full Text] [Related]
8. Effects of low-dose mirtazapine on driving performance in healthy volunteers.
Iwamoto K; Kawano N; Sasada K; Kohmura K; Yamamoto M; Ebe K; Noda Y; Ozaki N
Hum Psychopharmacol; 2013 Sep; 28(5):523-8. PubMed ID: 23813948
[TBL] [Abstract][Full Text] [Related]
9. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
[TBL] [Abstract][Full Text] [Related]
10. Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
Jongen S; Vuurman EFPM; Ramaekers JG; Vermeeren A
Psychopharmacology (Berl); 2018 Apr; 235(4):1283-1294. PubMed ID: 29500585
[TBL] [Abstract][Full Text] [Related]
11. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
[TBL] [Abstract][Full Text] [Related]
12. Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers.
Sasada K; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda Y; Ozaki N
Hum Psychopharmacol; 2013 May; 28(3):281-6. PubMed ID: 23661283
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate significantly reduces lapses of attention during on-road highway driving in patients with ADHD.
Verster JC; Roth T
J Clin Psychopharmacol; 2014 Oct; 34(5):633-6. PubMed ID: 24978156
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB
JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571
[TBL] [Abstract][Full Text] [Related]
15. Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study.
Morrison RL; Fedgchin M; Singh J; Van Gerven J; Zuiker R; Lim KS; van der Ark P; Wajs E; Xi L; Zannikos P; Drevets WC
Psychopharmacology (Berl); 2018 Apr; 235(4):1107-1119. PubMed ID: 29392371
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Fedgchin M; Trivedi M; Daly EJ; Melkote R; Lane R; Lim P; Vitagliano D; Blier P; Fava M; Liebowitz M; Ravindran A; Gaillard R; Ameele HVD; Preskorn S; Manji H; Hough D; Drevets WC; Singh JB
Int J Neuropsychopharmacol; 2019 Oct; 22(10):616-630. PubMed ID: 31290965
[TBL] [Abstract][Full Text] [Related]
17. On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers.
Vermeeren A; Jongen S; Murphy P; Moline M; Filippov G; Pinner K; Perdomo C; Landry I; Majid O; Van Oers ACM; Van Leeuwen CJ; Ramaekers JG; Vuurman EFPM
Sleep; 2019 Apr; 42(4):. PubMed ID: 30597112
[TBL] [Abstract][Full Text] [Related]
18. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.
Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG
Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980
[TBL] [Abstract][Full Text] [Related]
19. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
Leufkens TR; Lund JS; Vermeeren A
J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
[TBL] [Abstract][Full Text] [Related]
20. A pooled analysis of on-the-road highway driving studies in actual traffic measuring standard deviation of lateral position (i.e., "weaving") while driving at a blood alcohol concentration of 0.5 g/L.
Jongen S; Vermeeren A; van der Sluiszen NN; Schumacher MB; Theunissen EL; Kuypers KP; Vuurman EF; Ramaekers JG
Psychopharmacology (Berl); 2017 Mar; 234(5):837-844. PubMed ID: 28070617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
